Kimia Biosciences has been granted permission to manufacturing and marketing of new active pharmaceutical Ingredient ‘Fimasartan Potassium Trihydrate API’ by Central Drugs Standard Control Organization, Ministry of Health & Family Welfare.
Kimia Biosciences is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets.